Developing selective N-myristoyltransferase (NMT) inhibitors has been challenging. Here, the authors describe selective NMT inhibitors that can be used as multistage antimalarials, targeting dormant and developing forms of liver and blood stage.
- Diego Rodríguez-Hernández
- Kamalakannan Vijayan
- Morten Grøtli
